Handelsbanken Fonder AB - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$7,617
-12.2%
201,819
+6.0%
0.04%
-6.5%
Q2 2023$8,673
+32.3%
190,363
+17.7%
0.05%
+21.1%
Q1 2023$6,558
-18.2%
161,687
+2.8%
0.04%
-24.0%
Q4 2022$8,014
-99.9%
157,2370.0%0.05%
-12.3%
Q3 2022$8,469,000
-33.6%
157,237
-20.8%
0.06%
-31.3%
Q2 2022$12,756,000
+6.9%
198,599
+29.1%
0.08%
+25.8%
Q1 2022$11,929,000
-12.9%
153,843
-3.5%
0.07%
-1.5%
Q4 2021$13,690,000
+3.5%
159,478
-3.0%
0.07%
-2.9%
Q3 2021$13,221,000
-57.7%
164,376
-57.6%
0.07%
-57.7%
Q2 2021$31,221,000
+3.7%
387,839
+8.6%
0.16%
-4.7%
Q1 2021$30,121,000
-51.7%
357,138
-54.0%
0.17%
-54.9%
Q4 2020$62,332,000
-15.3%
776,820
-15.1%
0.38%
-29.7%
Q3 2020$73,570,000
-50.7%
914,820
-47.2%
0.54%
-15.0%
Q2 2020$149,266,000
+81.9%
1,733,640
+71.6%
0.63%
-64.1%
Q1 2020$82,042,000
+201.9%
1,010,500
+210.9%
1.77%
+275.7%
Q4 2019$27,176,000
+88.0%
325,000
+82.8%
0.47%
+67.9%
Q1 2019$14,457,000
+34.9%
177,800
+9.2%
0.28%
+29.6%
Q4 2018$10,715,000
-14.6%
162,8000.0%0.22%
+40.3%
Q3 2018$12,550,000
+20.7%
162,800
+15.6%
0.15%
-24.5%
Q2 2018$10,397,000
+12.9%
140,800
-0.6%
0.20%
+112.5%
Q1 2018$9,210,000
-17.0%
141,600
-17.5%
0.10%
-27.3%
Q4 2017$11,092,000
-15.0%
171,600
-17.5%
0.13%
-19.5%
Q3 2017$13,052,000
+107.3%
208,000
+100.0%
0.16%
+1.9%
Q2 2017$6,296,000
+30.5%
104,000
+11.8%
0.16%
+20.1%
Q1 2017$4,823,000
+89.7%
93,000
+39.5%
0.13%
+173.5%
Q4 2015$2,543,00066,6530.05%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders